NEW YORK, February 16, 2025 — Marshall Rose, a prominent New York real estate developer and philanthropist married to actress Candice Bergen, died February 15 at age 88 due to complications from Parkinson’s disease. His death has reignited discussions about the progressive neurological disorder, which affects nearly 10 million people globally, including celebrities such as Michael J. Fox and Alan Alda.
Parkinson’s Disease: A Debilitating Neurological Battle
Parkinson’s disease is caused by the degeneration of dopamine-producing neurons in the brain, particularly in the substantia nigra, leading to symptoms like tremors, muscle rigidity, and impaired balance. Non-motor effects, including depression, sleep disorders, and cognitive decline, further diminish quality of life.
Parkinson’s is not just a movement disorder—it systematically attacks the brain’s ability to regulate both physical and mental functions,
said Prof. Mike Chan, a renown stem cell scientist and bioregenerative specialist at the European Wellness Biomedical Group.
Current treatments manage symptoms but do not stop disease progression.
Celebrities Shed Light on Parkinson’s Struggles
- Michael J. Fox, 63, diagnosed in 1991, has raised over $1 billion for research through his foundation.
- Alan Alda, 88, revealed his diagnosis in 2018 and advocates for exercise therapies to slow symptom advancement.
- Neil Diamond, 83, retired from touring in 2018 due to Parkinson’s but continues composing music.
Rose’s death underscores the urgent need for therapies that address neurodegeneration rather than just symptoms.
Prof. Mike Chan’s Targeted Organ-Specific and Brain-Specific Regenerative Therapy
Prof. Chan’s European Wellness Centers worldwide employ targeted organ-specific and targeted brain-specific regenerative precursor stem cell therapy, a protocol designed to regenerate damaged neurons and restore dopaminergic function. Key elements include:
-
Targeted Organ-Specific and Brain-Specific Regenerative Precursor Stem Cell Therapy
- This therapy focuses on regenerating affected regions, including the frontal lobe, temporal lobe, medulla alba, cerebellum, corpus callosum, basal ganglia, substantia nigra, and CNS/brain, as recommended in the Compendium of Diseases.
- “These targeted stem cells migrate to damaged areas like the substantia nigra, potentially rebuilding dopamine pathways,” Chan explained. Peer-reviewed studies cite stem cells’ ability to secrete neuroprotective factors, reducing inflammation.
-
Peptide Therapy
- Custom peptides, such as GDNF (glial cell-derived neurotrophic factor) analogs, are used to enhance neuron survival and communication.
-
Holistic Support
- Protocols include detoxification to remove neurotoxic heavy metals, hyperbaric oxygen therapy to enhance neuroregeneration, antioxidant-rich diets, and tailored exercise plans to preserve motor function.
Why This Protocol Shows Promise
While traditional drugs like Levodopa temporarily replenish dopamine, Chan’s method aims to repair the root cause. A 2023 Journal of Regenerative Medicine study noted improved motor function in 65% of Parkinson’s patients receiving targeted regenerative precursor stem cell therapy, though larger trials are ongoing.
Bioregeneration isn’t a cure, but it offers a strategic slowdown of neurodegeneration and improved quality of life,
Chan said. Prof. Mike Chan has been treating Parkinson’s patients around the world, with notable testimonies from individuals such as Mr. Agassi and Tan Sri Bakri, whose cases are documented on the European Wellness website.
A Legacy of Awareness
As the world remembers Marshall Rose for his philanthropic contributions, his battle with Parkinson’s serves as a stark reminder of the urgent need for groundbreaking treatments. While conventional therapies provide symptom relief, they fall short in addressing the root causes of neurodegeneration.
Prof. Mike Chan’s targeted organ-specific and brain-specific regenerative precursor stem cell therapy represents a new frontier in biomedicine—one that offers renewed hope to millions living with this debilitating condition.
By merging cutting-edge regenerative science with holistic support, Chan and his team continue to push the boundaries of what’s possible in neurorestoration.
The journey to conquering Parkinson’s is far from over, but with each breakthrough, we move closer to a future where neurodegeneration is no longer an inevitable fate.
Follow European Wellness on:
Follow European Wellness Academy on:
Follow Prof. Dato’ Sri Dr. Mike Chan on:
Comments are closed.